| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Eur J Cardiothorac Surg 2001;19:537-538
© 2001 Elsevier Science NL
Letter to the Editor |
dizDepartment of Cardiovascular Surgery, Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkey
Received 22 December 2000; accepted 21 January 2001.
Corresponding author. Ay
e Çavu Sokak, No: 7/6, Huri Apt., Suadiye 81070 Istanbul, Turkey. Tel./fax: +90-216-3633642
e-mail: ckonuralp{at}usa.net
Key Words: Batista • Ventriculectomy • Heart failure • Papillary muscle • Tricusbid insufficiency
We read with great interest the article (November, 2000) by Drs Vural and Tademir [1]. We have several concerns regarding the paper.
As the authors emphasized, posterior left ventriculectomy or Batista procedure is an important surgical option for severe or end-stage heart failure.
We think the amount and extension of resected viable muscle segment is a very crucial point for this special procedure.
We noticed, in 41% (11/27) of the patients, the authors included anterior papillary muscle (APM) in the resected wall muscle. Although, they did not compare two techniques (resection vs. preservation of APM), we prefer to protect APM. It is clear that they defend resecting as large as possible of the left ventricular (LV) myocardium to obtain maximum benefit. However, Felipe and his colleagues [2] did not find any correlation between LV ejection fraction changes and the degree of myocardium resection.
In the other 59% (16/27) of the patients, they did not resect the APM, but they replaced the mitral valve without reattaching the cords to the ventricular wall.
Batista procedure improves systolic function while decreasing diastolic compliance, resulting in reduced ventricular function [3]. Thus, immediate hemodynamic improvements appear to drive mainly from a reduced severity of mitral regurgitation. Ventriculectomy ensures acute remodeling of the heart and decreasing chamber volume/mass ratio. Numerous clinical and experimental studies demonstrate the importance of preserving papillary continuity of the mitral valve. Lillehei [4] first reported on the preservation of papillary muscles and chordea tendinea and its benefits to ventricular function following mitral valve replacement (MVR). High incidence of postoperative ‘low cardiac output syndrome’ after MVR, subsequently introduced techniques of preservation of the mitral apparatus. Studies by Hansen [5] and Sarris [6] using load-independent measurement of LV contractility demonstrated that a division of all chordea tendinea was accompanied by a 47% reduction in LV maximal systolic elastance (Emax).
Furthermore, the effects of chordal detachment and reattachment on LV function were assessed by load-independent measurements of Emax. When all chordea were detached, a significant decline of LV contractility was seen, which has subsequently restorated to baseline levels after reattaching the native chordea by repair of the papillary muscles. Maintaining of chordal, annular, subvalvular continuity and mitral geometric relationship are considered very important in valvular surgery. These parameters maybe even more important for the patients with severely compromised LV function.
We think, for the ventricules that really need help, it is luxury that neglecting all of the advantageous we discussed above, just because of the fear of papillary muscle distortion.
Hepatomegaly, an important sign of the right heart failure, is considered as a strong indicator for the operative mortality. We couldn't find the incidence of tricusbid valve insufficiency accompanied to the hepatomegaly in the paper. Also, there is no any statement that if they did any surgical procedure (like annuloplasty, replacement) to the tricusbid valve. If they did not perform any procedure to the right side, why didn't they consider it? We would like to learn their opinion in this subject.
Finally, we want to correct some clerical errors in the paper. There are discrepancies between text (or Table 1, abstract) and Table 3 for preoperative LVESV (259±66 ml vs. 251±52 ml) and LVEDV (342±83 ml vs. 335±68 ml) values.
We would like to thank the authors for their contributions to such an important subject.
References
demir O. Mid-term results of partial left ventriculectomy in end-stage heart disease. Eur J Cardio-thorac Surg 2000;18:550-556.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
